Home > Insider Trading > Filing (0001773751-24-000312)

Filing Details

Accession Number:: 0001773751-24-000312
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-03 16:10:00
Reporting Period:: 2024-10-01

Accepted Time:: 2024-10-03 16:10:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773751	Hims & Hers Health Inc.	HIMS	Services-Offices & Clinics Of Doctors Of Medicine (8011)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1837796	Andrew Dudum	2269 Chestnut Street, #523 San Francisco CA 94123	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2024-10-01	188,888	$2.43	255,903	No	4	M	Direct
Class A Common Stock	Disposition	2024-10-01	94,444	$18.18	161,459	No	4	S	Direct
Class A Common Stock	Disposition	2024-10-01	94,444	$18.18	67,015	No	4	S	Direct
Class A Common Stock	Disposition	2024-10-01	144,444	$18.22	651,046	No	4	S	Indirect	Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (right to buy)	Disposition	2024-10-01	188,888	$0.00	188,888	$2.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
392,904		2030-06-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	1,315,881	Indirect	Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock	1,675,943	Indirect	Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock	534,491	Indirect	Held by Trustee of AD 2022 GRAT
Class A Common Stock	570,398	Indirect	Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock	418,986	Indirect	Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
Class A Common Stock	1,584,506	Indirect	Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock	891,735	Indirect	Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock	1,500	Indirect	Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
Class A Common Stock	2,874,769	Indirect	Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021

Footnotes

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.96 - $18.51. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.97 - $18.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.00 - $18.555. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.